L. Herbert Maurer
- Oncology top 1%
- Epidemiology top 5%
- Pulmonary and Respiratory Medicine top 2%
- Molecular Biology
- Pediatrics, Perinatology and Child Health top 5%
- Co-authors
- Peter M. SilberfarbR. Jackson ForcierGeorge D. SorensonOlive S. PettengillMichael C. PerryDoris H. Wurster‐HillRobert L. ComisO. Ross McIntyre
- Topics
- Lung Cancer Research Studies (24 papers)Neuroendocrine Tumor Research Advances (20 papers)Peptidase Inhibition and Analysis (7 papers)
- Journals
- The LancetJAMANucleic Acids Research
- Partner nations
- United StatesUnited KingdomDenmark
In The Last Decade
L. Herbert Maurer
57 papers receiving 2.7k citations
Peers
Comparison fields: 5 of 121
- Oncology 1.9k
- Epidemiology 881
- Pulmonary and Respiratory Medicine 867
- Molecular Biology 645
- Pediatrics, Perinatology and Child Health 296
Countries citing papers authored by L. Herbert Maurer
This map shows the geographic impact of L. Herbert Maurer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Herbert Maurer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Herbert Maurer more than expected).
Fields of papers citing papers by L. Herbert Maurer
This network shows the impact of papers produced by L. Herbert Maurer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Herbert Maurer. The network helps show where L. Herbert Maurer may publish in the future.
Co-authorship network of co-authors of L. Herbert Maurer
This figure shows the co-authorship network connecting the top 25 collaborators of L. Herbert Maurer. A scholar is included among the top collaborators of L. Herbert Maurer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. Herbert Maurer. L. Herbert Maurer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 10 | |
| 2 | 3 | |
| 3 | 98 | |
| 4 | 3 | |
| 5 | 78 | |
| 6 | 1 | |
| 7 | 4 | |
| 8 | 0 | |
| 9 | 46 | |
| 10 | 4 | |
| 11 | 20 | |
| 12 | 44 | |
| 13 | 32 | |
| 14 | 184 | |
| 15 | 26 | |
| 16 | 1 | |
| 17 | 167 | |
| 18 | 120 | |
| 19 | Combination chemotherapy with cisplatin, carmustine, dacarbazine, and tamoxifen in metastatic melanoma. | 187 |
| 20 | Clinical trial of combined therapy with adriamycin and cis-dichlorodiammineplatinum(II). | 3 |
About L. Herbert Maurer
L. Herbert Maurer is a scholar working on Oncology, Epidemiology and Pulmonary and Respiratory Medicine, having authored 58 papers that have together received 3.0k indexed citations. Recurring topics across this work include Lung Cancer Research Studies (24 papers), Neuroendocrine Tumor Research Advances (20 papers) and Peptidase Inhibition and Analysis (7 papers). The work is most often cited by research in Oncology (1.9k citations), Pulmonary and Respiratory Medicine (867 citations) and Epidemiology (881 citations). L. Herbert Maurer has collaborated with scholars based in United States, United Kingdom and Denmark. Frequent co-authors include Peter M. Silberfarb, R. Jackson Forcier, George D. Sorenson, Olive S. Pettengill, Michael C. Perry, Doris H. Wurster‐Hill, Robert L. Comis, O. Ross McIntyre, Walter L. Eaton and Robert T. Eagan. Their work appears in journals such as The Lancet, JAMA and Nucleic Acids Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.